Table 2 Adjusted predictors of discontinuation of first antidiabetic drug therapy during a 24-month follow-up period
Sulfonylurea (N = 1640) | Metformin (N = 266) | |||
|---|---|---|---|---|
Variable | Hazard Ratio | 95% Confidence Interval | Hazard Ratio | 95% Confidence Interval |
Black vs. White | 1.8 | 1.2, 2.7†† | 1.5 | 0.4, 5.0 |
Male vs. Female | 1.14 | 0.8, 1.6 | 1.6 | 0.6, 4.9 |
Age | 1.02 | 1.01, 1.04† | 1.0 | 0.9, 1.0 |
Low Income | 1.0 | 0.7, 1.5 | 3.3 | 0.9, 11.5 |
< High School Education | 0.5 | 0.1, 1.9 | 1.0 | 0.07, 14.1 |
HbA1c 7.0–9.0 vs. <7.0§ | 0.8 | 0.6, 1.3 | 0.4 | 0.05. 3.1 |
HbA1c > 9.0 vs. <7.0§ | 1.01 | 0.5, 1.9 | 4.6 | 0.5, 42.2 |
BMI (time-variant) | 1.001 | 1.0, 1.03 | 1.0 | 0.9, 1.1 |
# AHFS|| (time-variant) | 0.9 | 0.8, 1.1 | 0.9 | 0.5, 1.7 |
# of MD Visits (time-variant) | 1.0 | 0.8, 1.2 | 1.2 | 0.5, 2.5 |